RaySearch Laboratories issued an urgent field safety notice in Europe to warn on an issue with the dose calculation for the Siemens (NYSE:SI) virtual wedge in several of RaySearch’s RayStation treatment planning systems. The affected RayStation models listed in the safety notice out of Germany included RayStation 4.0, RayStation 4.5, RayStation 4.7, RayStation 4.9 (RayPlan 1), […]
RaySearch Laboratories
FDA clears RaySearch’s RayStation 8B
RaySearch yesterday announced it received FDA 510(k) clearance for its RayStation 8B treatment planning system. The RayStation 8B is a machine learning treatment planning system for the radiation oncology market. The system uses deep neural networks and is designed for automated treatment planning and automated organ segmentation to improve efficiency and consistency. The framework of […]
Accuray, RaySearch ink deal
Accuray (NSDQ:ARAY) said it inked a deal with RaySearch Laboratories to allow Accuray to co-market RaySearch’s RayCare oncology information system in several designated major radiation therapy markets RayCare is designed to handle logistical challenges present in modern radiation therapy centers by using high-performance radiation therapy algorithms, Sunnyvale, Calif.-based Accuray said. “In today’s complex healthcare environment it is […]
Ex-Biomet CEO Binder is Immucor’s new chief exec | Personnel Moves
Immucor said it named Jeffrey Binder, who led Biomet until its $13.34 billion merger with Zimmer (NYSE:ZMH), to be its new chairman, president & CEO. Binder replaces William Hawkins, the former Medtronic (NYSE:MDT) chief executive who took the reins at Immucor in 2011. Hawkins will assume the role of lead director on Immucor’s board, that company said. Immucor is […]